Cargando…

Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis

BACKGROUND: Several studies have investigated the value of the systemic immune-inflammation index (SII) for predicting cardiovascular disease (CVD), but the results were inconsistent. Therefore, a meta-analysis and systematic review were conducted to assess the correlation between SII and risk of CV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Zhen, Hu, Tingyi, Wang, Jin, Xiao, Ruoyi, Liao, Xibei, Liu, Mengsi, Sun, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393310/ https://www.ncbi.nlm.nih.gov/pubmed/36003917 http://dx.doi.org/10.3389/fcvm.2022.933913

Ejemplares similares

Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
por: Deng, Jian, et al.
Publicado: (2022)

Risk of Colorectal Cancer in Patients With Irritable Bowel Syndrome: A Meta-Analysis of Population-Based Observational Studies
por: Wu, Xinhui, et al.
Publicado: (2022)

Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis
por: Liu, Yifei, et al.
Publicado: (2023)

Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease
por: He, Lu, et al.
Publicado: (2022)

Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease
por: Liu, Xiaoliang, et al.
Publicado: (2021)

Biomarkers of Cardiac Injury, Renal Injury, and Inflammation Are Strong Mediators of Sex-Associated Death in COVID-19
por: Lumish, Heidi S., et al.
Publicado: (2022)

Editorial: Cardioimmunology: Inflammation and Immunity in Cardiovascular Disease
por: Lazzerini, Pietro Enea, et al.
Publicado: (2019)

Association of systemic immune inflammation index and system inflammation response index with clinical risk of acute myocardial infarction
por: Wei, Xing, et al.
Publicado: (2023)

Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension
por: Zhao, Songfeng, et al.
Publicado: (2023)

Identification of potential biomarkers of inflammation-related genes for ischemic cardiomyopathy
por: Wang, Jianru, et al.
Publicado: (2022)

Value of the Systemic Immune-Inflammatory Index (SII) in Predicting the Prognosis of Patients With Peripartum Cardiomyopathy
por: Zhang, Yuan, et al.
Publicado: (2022)

Role of Cardiovascular Magnetic Resonance to Assess Cardiovascular Inflammation
por: Filomena, Domenico, et al.
Publicado: (2022)

High sensitivity troponins: A potential biomarkers of cardiovascular risk for primary prevention
por: Leite, Luis, et al.
Publicado: (2022)

Machine learning-based integration develops biomarkers initial the crosstalk between inflammation and immune in acute myocardial infarction patients
por: Li, Hongyu, et al.
Publicado: (2023)

Editorial: Inflammation and immunomodulation in cardiovascular remodeling
por: Ewing, Mark, et al.
Publicado: (2022)

Cardiovascular Risk Factors and Social Development Index
por: Martínez-García, Mireya, et al.
Publicado: (2021)

Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction
por: Fang, Caoyang, et al.
Publicado: (2022)

DPP3: From biomarker to therapeutic target of cardiovascular diseases
por: Ye, Peng, et al.
Publicado: (2022)

Association Between Hemoglobin Glycation Index and Risk of Cardiovascular Disease and All Cause Mortality in Type 2 Diabetic Patients: A Meta-Analysis
por: Wu, Jian-di, et al.
Publicado: (2021)

Immune-related potential biomarkers and therapeutic targets in coronary artery disease
por: Liu, Chaosheng, et al.
Publicado: (2023)

The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus
por: Xu, Shuai, et al.
Publicado: (2022)

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
por: Zhang, Meng-Wan, et al.
Publicado: (2021)

Association of Systemic Immune-Inflammation Index With Short-Term Mortality of Congestive Heart Failure: A Retrospective Cohort Study
por: Tang, Yiyang, et al.
Publicado: (2021)

Systemic immune-inflammation index is associated with coronary heart disease: a cross-sectional study of NHANES 2009–2018
por: Ma, Jiwen, et al.
Publicado: (2023)

Obesity and Cardiovascular Disease: The Emerging Role of Inflammation
por: Khafagy, Rana, et al.
Publicado: (2021)

Editorial: Extracellular vesicles in cardiovascular inflammation and calcification
por: Krohn, Jona B., et al.
Publicado: (2022)

Editorial: Thrombo-inflammation in cardiovascular disease and health
por: Jung, Richard G., et al.
Publicado: (2023)

Acute effects of singing on cardiovascular biomarkers
por: Somayaji, Kamila, et al.
Publicado: (2022)

Imaging Assessment of Endothelial Function: An Index of Cardiovascular Health
por: Minhas, Anum S., et al.
Publicado: (2022)

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Identification of CALU and PALLD as Potential Biomarkers Associated With Immune Infiltration in Heart Failure
por: Liu, Xing, et al.
Publicado: (2021)

Corrigendum: Association of systemic immune-inflammation index with short-term mortality of congestive heart failure: A retrospective cohort study
por: Tang, Yiyang, et al.
Publicado: (2022)

The prognostic value of advanced lung cancer inflammation index (ALI) in elderly patients with heart failure
por: Yuan, Xiao, et al.
Publicado: (2022)

Association Between Triglyceride-Glucose Index and Hypertension: A Meta-Analysis
por: Wang, Yi, et al.
Publicado: (2021)

Sortilin as a Biomarker for Cardiovascular Disease Revisited
por: Møller, Peter Loof, et al.
Publicado: (2021)

Editorial: Classical and Novel Biomarkers for Cardiovascular Disease
por: Perticone, Maria, et al.
Publicado: (2022)

Editorial: Insights in cardiovascular therapeutics 2022—cardiovascular innate immunity
por: Xu, Keman, et al.
Publicado: (2023)

Cardiovascular Risk According to Body Mass Index in Women of Reproductive Age With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Zhuang, Chenchen, et al.
Publicado: (2022)

Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Luo, Jin-Wen, et al.
Publicado: (2021)

Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study
por: Cho, Yun Kyung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s6qsln18m2gks15k3rcljvg8qu